We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+7.68%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$413M
AUM Growth
-$3.2M
(-0.77%)
Cap. Flow
-$7.27M
Cap. Flow
% of AUM
-1.76%
Top 10 Holdings %
Top 10 Hldgs %
30.14%
Holding
1,129
New
83
Increased
245
Reduced
309
Closed
247
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$21.4M |
| 2 |
Stellantis
STLA
|
+$18M |
| 3 |
CNH
CNH Industrial
CNH
|
+$11.6M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.3M |
| 5 |
iShares S&P 500 Value ETF
IVE
|
+$6.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$23.5M |
| 2 |
Linde
LIN
|
+$8.45M |
| 3 |
Visa
V
|
+$5.42M |
| 4 |
Alcon
ALC
|
+$3.14M |
| 5 |
T-Mobile US
TMUS
|
+$3.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.6% |
| 2 | Technology | 15.31% |
| 3 | Miscellaneous | 15.03% |
| 4 | Industrials | 9.82% |
| 5 | Financials | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Cboe Global Markets
CBOE
$28.2B
| $119K | 0.03% |
+916
| New | +$118K |
|
427
Lennar Class A
LEN
$18.9B
| $116K | 0.03% |
1,030
+665
| +182% | +$68K |
|
428
AllianceBernstein
AB
$3.3B
| $112K | 0.03% |
2,290
| – | – |
|
429
Morgan Stanley
MS
$318B
| $111K | 0.03% |
1,133
-5,600
| -83% | -$558K |
|
430
CVS Health
CVS
$117B
| $111K | 0.03% |
1,075
+744
| +225% | +$68.8K |
|
431
Construction Partners
ROAD
$5.4B
| $110K | 0.03% |
3,749
-12,437
| -77% | -$434K |
|
|
NREF
432
NexPoint Real Estate Finance
NREF
$301M
| $109K | 0.03% |
5,680
| – | – |
|
433
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $108K | 0.03% |
963
| – | – |
|
|
PPLT
434
abrdn Physical Platinum Shares ETF
PPLT
$2.13B
| $107K | 0.03% |
11,910
| – | – |
|
435
Guardant Health
GH
$23.5B
| $106K | 0.03% |
1,061
-1,405
| -57% | -$145K |
|
|
KRTX
436
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $105K | 0.03% |
+803
| New | +$104K |
|
|
BLDP
437
Ballard Power Systems
BLDP
$633M
| $104K | 0.03% |
8,261
-10,314
| -56% | -$156K |
|
438
iShares Silver Trust
SLV
$30.7B
| $103K | 0.03% |
4,799
| – | – |
|
439
Alector
ALEC
$215M
| $103K | 0.02% |
4,983
+4,866
| +4,159% | +$110K |
|
440
iShares Russell 2000 Value ETF
IWN
$14.1B
| $102K | 0.02% |
616
-946
| -61% | -$158K |
|
441
EOG Resources
EOG
$76B
| $99.9K | 0.02% |
1,125
+1,112
| +8,554% | +$99.9K |
|
442
Phathom Pharmaceuticals
PHAT
$622M
| $99.5K | 0.02% |
5,058
| – | – |
|
|
DSL
443
DoubleLine Income Solutions Fund
DSL
$1.17B
| $98.9K | 0.02% |
6,137
-3,163
| -34% | -$54.1K |
|
|
CKPT
444
DELISTED
Checkpoint Therapeutics
CKPT
| $97.2K | 0.02% |
3,126
-1,697
| -35% | -$56.2K |
|
445
Digital Realty Trust
DLR
$67.2B
| $93.4K | 0.02% |
528
+309
| +141% | +$49.5K |
|
446
Freshpet
FRPT
$2.98B
| $92K | 0.02% |
966
-288
| -23% | -$35.7K |
|
447
Simon Property Group
SPG
$65.7B
| $91.2K | 0.02% |
571
-486
| -46% | -$74.2K |
|
448
Nuveen Quality Municipal Income Fund
NAD
$2.5B
| $89.2K | 0.02% |
5,537
-2,863
| -34% | -$44.8K |
|
449
Las Vegas Sands
LVS
$26.6B
| $89.1K | 0.02% |
2,366
-336
| -12% | -$12.9K |
|
450
Erasca
ERAS
$5.37B
| $87.1K | 0.02% |
+5,589
| New | +$95.7K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2021 Portfolio in Review
As of Q4 2021, Exane Derivatives held 1,129 positions worth $413M, down 0.77% from $417M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Exane Derivatives's Q4 2021 filing shows 83 new, 245 increased, 309 reduced and 247 closed positions. Its largest new stake was EngageSmart, Inc.: 45,605 shares worth $1.1M. The largest sale was UBS Group, an estimated $23.5M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 11% a quarter earlier, followed by Technology and Miscellaneous.
- Exane Derivatives's largest Q4 2021 buy was EngageSmart, Inc.: 45,605 shares worth $1.1M.
- Exane Derivatives added most to Ferrari in Q4 2021, an estimated $21.4M increase.
- Exane Derivatives's biggest Q4 2021 reduction was UBS Group, cutting an estimated $23.5M.
- Exane Derivatives fully exited Visa in Q4 2021, selling an estimated $5.42M.
- Exane Derivatives's ten largest holdings make up 30% of its $413M portfolio in Q4 2021.
- Exane Derivatives opened 83 new positions and closed 247 in Q4 2021.
- Exane Derivatives's portfolio value fell 0.77% quarter-over-quarter to $413M.
Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.